ArticleImmunity, inflammation and disease2024

The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19.

Seyed Askar Roghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.